ChampionX Corp.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US15872M1045
USD
25.81
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About ChampionX Corp. stock-summary
stock-summary
ChampionX Corp.
Specialty Chemicals
ChampionX Corporation, formerly known as Apergy Corporation, provides chemistry solutions and engineered equipment and technologies that help companies drill for and produce oil and gas. The Company operates through two segments: Production & Automation Technologies and Drilling Technologies. Its Production & Automation Technologies segment offerings consist of artificial lift equipment and solutions, including rod pumping systems, electric submersible pump systems, progressive cavity pumps and drive systems and plunger lifts, as well as a full automation and digital offering consisting of equipment, software and Industrial Internet of Things solutions for downhole monitoring, wellsite productivity enhancement and asset integrity management. Its Drilling Technologies segment offering provides polycrystalline diamond cutters and bearings.
Company Coordinates stock-summary
Company Details
2445 TECHNOLOGY FOREST BLVD, BUILDING 4, FLOOR 12 THE WOODLANDS TX : 77381
stock-summary
Tel: 1 281 40357721 713 2308031
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 139 Schemes (55.13%)

Foreign Institutions

Held by 186 Foreign Institutions (17.81%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Daniel Rabun
Independent Chairman of the Board
Mr. Sivasankaran Somasundaram
President, Chief Executive Officer, Director
Ms. Heidi Alderman
Director
Mr. Stuart Porter
Director
Ms. Mamatha Chamarthi
Independent Director
Mr. Kenneth Fisher
Chief Financial Officer, Executive Vice President
Mr. Gary Luquette
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
864 Million
(Quarterly Results - Mar 2025)
Net Profit:
89 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 4,925 Million (Small Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

151.69%

stock-summary
Debt Equity

0.04

stock-summary
Return on Equity

16.56%

stock-summary
Price to Book

2.57